Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001301138 | SCV001490300 | uncertain significance | Acute myeloid leukemia | 2020-01-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals with CEBPA-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a frameshift in the CEBPA gene (p.Arg343Profs*60). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 16 amino acids of the CEBPA protein and extend the protein by an additional 43 amino acids. |